FDA Inspection 1032363 — QuVa Pharma, Inc.
The FDA completed an inspection of QuVa Pharma, Inc. on Nov 30, 2017 in Bloomsbury, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 30, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bloomsbury, NJ (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 2011 | 21 CFR 211.188(a) | Accurate reproduction |
| 4302 | 21 CFR 211.56(b) | Written sanitation procedures not followed |